References
- Barker P B, Lee R R, McArthur J C. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995; 195: 58–64, [PUBMED], [INFOTRIEVE], [CSA]
- Bates T E, Strangward M, Keelan J, Davey G P, Munro P M, Clark J B. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1996; 7: 1397–1400, [PUBMED], [INFOTRIEVE], [CSA]
- Benbrik E, Chariot P, Bonavaud S, Ammi-Said M, Frisdal E, Rey C. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci 1997; 149: 19–25, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp B D. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 2002; 51: 51–58, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chang L, Miller B L, McBride D, Cornford M, Oropilla G, Buchthal S. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995 197: 525–531, [PUBMED], [INFOTRIEVE], [CSA]
- Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurolog. 1999 53: 782–789, [CSA]
- Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A. N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 2001; 77: 408–415, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Furman P A, Fyfe J A, St Clair M H, Weinhold K, Rideout J L, Freeman G A. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A 1986; 83: 8333–8337, [PUBMED], [INFOTRIEVE], [CSA]
- Glynn S L, Yazdanian M. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents. J Pharm Sci 1998; 87: 306–310, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Haas R H. A comparison of genetic mitochondrial disease and nucleoside analogue toxicity. Does fetal nucleoside toxicity underlie reports of mitochondrial disease in infants born to women treated for HIV infection. Ann N Y Acad Sci 2000; 918: 247–261, [PUBMED], [INFOTRIEVE], [CSA]
- Iranzo A, Moreno A, Pujol J, Marti-Fabregas J, Domingo P, Molet J. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J Neurol Neurosurg Psychiatry 1999; 66: 520–523, [PUBMED], [INFOTRIEVE], [CSA]
- Kakuda T N. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000; 22: 685–708, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996; 199: 805–810, [PUBMED], [INFOTRIEVE], [CSA]
- Lim S E, Copeland W C. Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem 2001; 276: 23616–23623, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lopez-Villegas D, Lenkinski R E, Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1997; 94: 9854–9859, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Martin J L, Brown C E, Matthews-Davis N, Reardon J E. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 1994; 38: 2743–2749, [PUBMED], [INFOTRIEVE], [CSA]
- McLean M A, Woermann F G, Barker G J, Duncan J S. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn Reson Med 2000; 44: 401–411, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Menon D K, Ainsworth J G, Cox I J, Coker R C, Sargentoni J, Coutts G A. Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992; 16: 538–542, [PUBMED], [INFOTRIEVE], [CSA]
- Meyerhoff D J, MacKay S, Bachman L, Poole N, Dillon W P, Weiner M W. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 1993; 43: 509–515, [PUBMED], [INFOTRIEVE], [CSA]
- Meyerhoff D J, MacKay S, Poole N, Dillon W P, Weiner M W, Fein G. N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals. Magn Reson Imaging 1994; 12: 653–659, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moffett J R, Namboodiri M A, Cangro C B, Neale J H. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991; 2: 131–134, [PUBMED], [INFOTRIEVE], [CSA]
- Möller H E, Vermathen P, Lentschig M G, Schuierer G, Schwarz S, Wiedermann D. Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 1999; 9: 10–18, [CROSSREF], [CSA]
- Naviaux R K, Markusic D, Barshop B A, Nyhan W L, Haas R H. Sensitive assay for mitochondrial DNA polymerase gamma. Clin Chem 1999; 45: 1725–1733, [PUBMED], [INFOTRIEVE], [CSA]
- Paley M, Cozzone P J, Alonso J, Vion-Dury J, Confort-Gouny S, Wilkinson I D. A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses 1996; 12: 213–222, [PUBMED], [INFOTRIEVE], [CSA]
- Paley M, Wilkinson I D, Hall-Craggs M A, Chong W K, Chinn R J, Harrison M J. Short echo time proton spectroscopy of the brain in HIV infection/AIDS. Magn Reson Imaging 1995; 13: 871–875, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pan-Zhou X R, Cui L, Zhou X J, Sommadossi J P, Darley-Usmar V M. Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrob Agents Chemother 2000; 44: 496–503, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Provencher S W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672–679, [PUBMED], [INFOTRIEVE], [CSA]
- Salvan A M, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone P J. Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Hum Retroviruses 1997a; 13: 1055–1066, [PUBMED], [INFOTRIEVE], [CSA]
- Salvan A M, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone P J. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol 1997b; 32: 485–495, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schweinsburg B C, Taylor M J, Alhassoon O M, Videen J S, Brown G G, Patterson T L. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res 2001; 25: 924–934, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schweinsburg B C, Taylor M J, Videen J S, Alhassoon O M, Patterson T L, Grant I. Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. Alcohol Clin Exp Res 2000; 24: 699–705, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, Vagnozzi R. N-acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J Neurotrauma 2001; 18: 977–991, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Simmons M L, Frondoza C G, Coyle J T. Immunocytochemical localization of N-acetyl aspartate with monoclonal antibodies. Neuroscience 1991; 45: 37–45, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Simone I L, Federico F, Tortorella C, Andreula C F, Zimatore G B, Giannini P. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 1998; 64: 516–523, [PUBMED], [INFOTRIEVE], [CSA]
- Tracey I, Carr C A, Guimaraes A R, Worth J L, Navia B A, Gonzalez R G. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 1996; 46: 783–788, [PUBMED], [INFOTRIEVE], [CSA]
- Vion-Dury J, Nicoli F, Salvan A M, Confort-Gouny S, Dhiver C, Cozzone P J. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 1995; 345: 60–61, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wilkinson I D, Miller R F, Miszkiel K A, Paley M N, Hall-Craggs M A, Baldeweg T. Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. AIDS 1997; 11: 289–295, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wilkinson I D, Miller R F, Paley M N, Miszkiel K A, Kendall B E, Hall-Craggs M A. Cerebral proton magnetic resonance spectroscopy in cytomegalovirus encephalitis and HIV leucoencephalopathy/encephalitis. AIDS 1996; 10: 1443–1444, [PUBMED], [INFOTRIEVE], [CSA]
- Youssef J A, Badr M Z. Disruption of mitochondrial energetics and DNA synthesis by the anti-AIDS drug dideoxyinosine. Toxicol Lett 1992; 60: 197–202, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]